Advance Agrolife IPO is a mainboard offering set to open for subscription from September 30 to October 3, 2025, with a price band of ₹95 to ₹100 per equity share and a minimum lot size of 150 shares. Incorporated in 2002, Advance Agrolife operates in the agrochemical sector, manufacturing a diverse range of crop protection products such as insecticides, herbicides, fungicides, plant growth regulators, and bio-fertilizers. With a revenue of around ₹455 crore and expanding product portfolio, the Advance Agrolife IPO aims to raise ₹192.86 crore to support working capital and general corporate purposes.
₹00
₹100
₹
Expert Opinions
Market sentiment for Advance Agrolife IPO is positive, reflecting investor interest in the agrochemical sector’s steady growth potential. The company’s strengths include a diversified product portfolio covering insecticides, herbicides, fungicides, and bio-fertilizers, alongside a well-established manufacturing base and extensive distribution network across India and select export markets. Risks include exposure to regulatory changes, dependency on agricultural subsidies, and competition from alternative crop protection methods.
The valuation analysis for financial year 2025 highlights the Advance Agrolife IPO with a Return on Equity (ROE) of 25.42%, Return on Capital Employed (ROCE) of 27.02%, and Net Asset Value (NAV) of ₹22.42, showcasing robust profitability and asset efficiency. From a long-term investment perspective, the IPO offers potential for growth driven by increasing agricultural productivity and expanding demand for crop protection solutions.
Investor Considerations
Advance Agrolife has shown steady company performance with 10% revenue growth to ₹502.88 crore and moderate profitability with a PAT margin of 5.10% in FY 2025. The agrochemical sector outlook remains positive amid rising demand for crop protection and sustainable farming practices in India. The Advance Agrolife IPO valuation for financial year 2025 reveals a Price to Book Value of 5.98, EBITDA Margin of 9.61%, and Debt to Equity ratio of 0.80, indicating sound fundamentals with manageable leverage.
Growth prospects are supported by product diversification, expanding domestic market reach, and export opportunities. Risks include regulatory changes, subsidy reduction, and quality control challenges. The Advance Agrolife IPO suits investors with a long-term growth horizon seeking exposure to an established player in the agrochemical sector, while short-term investors should consider sector-linked volatility and execution risks.
FAQs
Advance Agrolife IPO Current GMP is ₹15.
Advance Agrolife IPO Expected Returns is 15.00%.
Advance Agrolife IPO estimated listing price is ₹115.